Bio-Medical Unit and Applications for Cancer Treatment

Abstract

An in vivo cancer treatment system includes a plurality of bio-medical units, a communication control device, and a wireless power source device. A bio-medical unit of the plurality of bio-medical units includes a power harvesting module operable to convert a wireless power source into a supply voltage; a communication module operable to communication data, wherein the communication unit is powered by the supply voltage; and a field generation module operable to generate a type of electromagnetic field, wherein the field generation module is powered by the supply voltage. The communication control device communicates with the plurality of bio-medical units to facilitate treatment of cancer cells within the body. The wireless power source device generates the wireless power source.

What is claimed is: 
     
         1 . A bio-medical unit configured in vivo comprising:
 power harvesting circuitry configured to convert received wireless power into a supply voltage;   communication circuitry powered by the supply voltage and configured to receive data including a selected power level regarding an application of a polarized or ionized treatment drug; and   field generation circuitry powered by the supply voltage and configured in vivo with adjustable power levels to generate an electromagnetic field with the selected power level to apply the polarized or ionized treatment drug within an in vivo localized area.   
     
     
         2 . The bio-medical unit of  claim 1 , wherein the communication circuitry comprises at least one of:
 a radio frequency (RF) transceiver configured to transceive RF data signals with a communication control device;   a millimeter wave (MMW) transceiver configured to transceive MMW data signals with a communication control device; or   a magnetic resonance transceiver configured to transceive magnetic resonance data signals with a communication control device.   
     
     
         3 . The bio-medical unit of  claim 1 , wherein the field generation circuitry is further configured to, when the treatment drug is ionized, determine a power level of an electric field to contain the ionized treatment drug approximately within the in vivo localized area and generate the electric field with the power level to contain the polarized or ionized treatment drug approximately within the in vivo localized area. 
     
     
         4 . The bio-medical unit of  claim 1 , wherein the field generation circuitry is further configured to, when the treatment drug is polarized, determine a power level of a magnetic field to contain the polarized treatment drug approximately within the in vivo localized area and generate the magnetic field with the power level to contain the polarized treatment drug approximately within the in vivo localized area. 
     
     
         5 . The bio-medical unit of  claim 1  further comprising first dispensing circuitry configured in vivo to:
 store the polarized or ionized treatment drug in vivo; and 
 dispense at least a portion of the polarized or polarized or ionized treatment drug in an in vivo localized area in response to a control signal. 
 
     
     
         6 . The bio-medical unit of  claim 5 , further comprising second dispensing circuitry configured in vivo to:
 store a second substance that contains a differing polarized or ionized treatment drug; and   dispense at least a portion of the second substance in the in vivo localized area in response to a second control signal.   
     
     
         7 . The bio-medical unit of  claim 1 , further comprising propulsion circuitry configured to move the bio-medical unit in accordance with at least one control signal. 
     
     
         8 . The bio-medical unit of  claim 1 , further comprising imaging circuitry configured to generate image data regarding the treatment. 
     
     
         9 . The bio-medical unit of  claim 1 , wherein the field generation circuitry comprises at least one of:
 a radio frequency (RF) transmitter to transmit RF signals to facilitate RF radiation treatment; or   a millimeter wave (MMW) transmitter to transmit MMW signals to facilitate MMW radiation treatment.   
     
     
         10 . The bio-medical unit of  claim 1 , wherein the communication circuitry is further configured to:
 receive a first control signal that contains instructions for a first pattern of treatment to be performed; or   receive a second control signal that contains instructions for a second pattern of treatment to be performed.   
     
     
         11 . A bio-medical unit, comprising:
 communication circuitry configured to receive a communication that includes instructions to apply an electromagnetic field at a directed power level; and   field generation circuitry configured in vivo in response to a control signal to generate an electromagnetic field at the directed power level in an in vivo localized area to apply at least one of a polarized treatment drug or an ionized treatment drug within the in vivo localized area.   
     
     
         12 . The bio-medical unit of  claim 11 , wherein the treatment drug is ionized and the field generation circuitry is configured to generate an electric field in the in vivo localized area to control positioning of the ionized treatment drug. 
     
     
         13 . The bio-medical unit of  claim 11 , wherein the treatment drug is polarized and the field generation circuitry is configured to generate a magnetic field in the in vivo localized area to area to control positioning of the polarized treatment drug. 
     
     
         14 . The bio-medical unit of  claim 11 , wherein the field generation circuitry is further configured to at least one of:
 generate an electric field to charge a substance that contains the ionized treatment drug in the in vivo localized area; or   generate a magnetic field to magnetize a substance that contains the polarized treatment drug in the in vivo localized area.   
     
     
         15 . The bio-medical unit of  claim 11  further comprising:
 first dispensing circuitry configured to dispense a first polarized or ionized treatment drug in vivo; and 
 second dispensing circuitry configured to dispense a second polarized or ionized treatment drug in vivo. 
 
     
     
         16 . The bio-medical unit of  claim 11  further comprising propulsion circuitry configured to move the bio-medical unit in accordance with control signals received by the communication circuitry. 
     
     
         17 . A method for treatment of cancer, comprising:
 determining a power level for an electromagnetic field for controlling positioning of a polarized treatment drug within an in vivo localized area; and   generating by a biomedical unit in vivo the electromagnetic field that interacts with the polarized treatment drug within the in vivo localized area with the power level to controlling positioning of the polarized treatment drug.   
     
     
         18 . The method of  claim 17 , further comprising dispensing at least a portion of the polarized treatment drug by the biomedical unit in vivo. 
     
     
         19 . The method of  claim 17 , further comprising:
 receiving instructions by the biomedical unit to position at a directed location; and   moving to the directed location by the biomedical unit using propulsion circuitry.   
     
     
         20 . The method of  claim 17 , further comprising generating image data regarding the treatment using imaging circuitry.